I think they are starting to panic, and one of them will break.
I don’t think I have ever seen the shorts panic on MSB - just sayin’
That said, with the current short figure outstanding of > 62 million shares short sold it would be a wild ride watching them cover if a CHF deal remotely close to this one was announced out of the blue …. Rexlemestrocel-L is certainly further advanced than it was over a decade ago and the extensive data from the phase 3 DREAM CHF trial is impressive enough to warrant a deal of at least this calibre IMO ….
GLTAH
https://www.genengnews.com/topics/t...-commercialize-mesoblast-stem-cell-therapies/
Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies
December 8, 2010
Deal includes $130 million up front and a $220 million equity payment for a 19.99% stake in Aussie firm.
MSB Trading 2022, The TurnAround, page-319
-
- There are more pages in this discussion • 730 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |